⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
MCX - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.5
| Stock Code | MCX | Market Cap | 66,397 Cr. | Current Price | 2,603 ₹ | High / Low | 2,706 ₹ |
| Stock P/E | 92.0 | Book Value | 81.8 ₹ | Dividend Yield | 0.23 % | ROCE | 31.9 % |
| ROE | 23.9 % | Face Value | 2.00 ₹ | DMA 50 | 2,404 ₹ | DMA 200 | 1,969 ₹ |
| Chg in FII Hold | 1.64 % | Chg in DII Hold | -1.34 % | PAT Qtr | 307 Cr. | PAT Prev Qtr | 156 Cr. |
| RSI | 59.1 | MACD | 57.2 | Volume | 61,48,184 | Avg Vol 1Wk | 38,19,252 |
| Low price | 905 ₹ | High price | 2,706 ₹ | PEG Ratio | 2.03 | Debt to equity | 0.00 |
| 52w Index | 94.3 % | Qtr Profit Var | 151 % | EPS | 28.3 ₹ | Industry PE | 55.9 |
📊 Financials
- Revenue & Profitability: PAT surged from ₹156 Cr. to ₹307 Cr. (+151%), showing strong growth momentum. EPS at ₹28.3 is solid.
- Margins & Returns: ROCE (31.9%) and ROE (23.9%) highlight strong efficiency and profitability.
- Debt: Debt-to-equity ratio of 0.00 → virtually debt-free, ensuring financial stability.
- Cash Flow: Strong profitability and zero leverage support healthy cash flows.
💹 Valuation
- P/E Ratio: 92.0 vs Industry PE of 55.9 → Significantly overvalued compared to peers.
- P/B Ratio: ~31.8 (Price ₹2,603 / Book Value ₹81.8) → Extremely expensive on book value basis.
- PEG Ratio: 2.03 → Growth partially justifies valuation but still stretched.
- Intrinsic Value: Current price trades well above fair value estimates.
🏢 Business Model & Competitive Advantage
- MCX operates as India’s leading commodity exchange, benefiting from monopoly-like positioning.
- Competitive advantage lies in scale, regulatory backing, and strong market share.
- Dividend yield of 0.23% is low, reflecting reinvestment focus rather than shareholder payouts.
📈 Entry Zone & Long-Term Guidance
- Entry Zone: Attractive near ₹2,200–2,350 range (below current levels, closer to DMA 200 at ₹1,969).
- Long-Term Holding: Suitable for investors seeking exposure to commodity markets. Accumulation at lower valuations is recommended due to stretched multiples.
✅ Positive
- Strong PAT growth (+151%) shows robust earnings momentum.
- Debt-free balance sheet ensures financial safety.
- High ROCE and ROE indicate efficient capital use.
- FII holdings increased (+1.64%), showing foreign investor confidence.
⚠️ Limitation
- Valuation multiples (P/E, P/B) are extremely high compared to industry averages.
- Dividend yield is very low (0.23%).
- Stock price near 52W high limits upside potential.
📉 Company Negative News
- DII holdings reduced (-1.34%), showing cautious domestic sentiment.
- High valuation may deter fresh institutional buying.
📈 Company Positive News
- PAT more than doubled QoQ, reflecting strong operational performance.
- FII holdings increased, signaling global investor confidence.
- Technical momentum remains strong (MACD +57.2, RSI 59.1).
🏭 Industry
- Commodity exchange industry benefits from rising trading volumes and financial market deepening.
- Industry PE at 55.9 suggests peers trade at lower valuations, highlighting MCX’s premium positioning.
🔎 Conclusion
- MCX is fundamentally strong with robust earnings growth, high efficiency, and zero debt.
- However, valuations are stretched, making current levels unattractive for fresh entry.
- Best strategy: Accumulate near ₹2,200–2,350 range for long-term holding, while avoiding aggressive buying at current highs.